S. 4447Senate118th Congress (2023-2025)Introduced

Allowing Greater Access to Safe and Effective Contraception Act

Sponsored by Joni ErnstSen. Joni Ernst (R-IA)
Introduced June 4, 2024

AI-Generated Summary

Updated January 20, 2026 at 5:06 PM UTC

The bill aims to expand women's access to safe, effective oral contraceptive pills by speeding up the FDA review of supplemental applications and eliminating associated fees. It also requires a Government Accountability Office study on how federal programs have funded contraceptive services over the past 15 years. The measures affect pharmaceutical manufacturers, the FDA, and women of all ages, with special rules for those under 18.

Key Provisions

  • The Secretary of Health and Human Services must give priority review to any supplemental application for an oral contraceptive intended for routine use, excluding emergency contraceptives and drugs also approved for induced abortion.
  • The application fee required under the Food, Drug, and Cosmetic Act is waived for any supplemental application that receives this priority review.
  • For individuals under 18, any oral contraceptive eligible for priority review remains subject to existing OTC restrictions under the law.
  • The priority‑review and fee‑waiver rules apply to supplemental applications pending at enactment and to those submitted afterward.
  • The Comptroller General must, within one year, study and report to Congress on the amount of federal funding for contraception (including reimbursement, inventory, training, and education) over the prior 15 years across programs such as Medicare, Medicaid, Indian Health Service, health exchanges, federally‑qualified health centers, Title X, TANF, and TRICARE.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateCalendars Latest Action

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 418.

June 5, 2024

View full timeline
SenateIntro Referral

Introduced in Senate

June 4, 2024

SenateCalendars

Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

June 4, 2024

SenateCalendars

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 418.

June 5, 2024

Floor Debate

9 members

What members said about S. 4447 on the floor

4 Republicans5 Democrats
Benjamin L. Cardin
Sen. Benjamin L. CardinD-MD · Jun 5, 2024

Madam President, I rise today to urge my colleagues to join me in supporting the Right to Contraception Act. Now more than ever, it is vital to codify reproductive rights. The right to contraception…

Joni Ernst
Sen. Joni ErnstR-IA · Jun 5, 2024

The so-called Right to Contraception Act goes far beyond the scope of providing access to contraception. It is important the American people understand what the Democrats are peddling. Senator…

Bill Cassidy
Sen. Bill CassidyR-LA · Jun 5, 2024

Madam President, I ask unanimous consent to ask that baby to come back into the spectators' Gallery. That was the sweetest noise we have heard here for quite some time. Right to Contraception Act…

Ted Cruz
Sen. Ted CruzR-TX · Jun 5, 2024

Madam President, I want to thank the Senator from Iowa for her legislation, important legislation, protecting the right to birth control and making it easier for women to have access to birth control…

Tina Smith
Sen. Tina SmithD-MN · Jun 5, 2024

Madam President, reserving the right to object, I have great respect for my colleague from Iowa, our neighbor to the south, but we just disagree on this issue. I think that this is an attempt by…

Show 5 more
Charles E. Schumer
Sen. Charles E. SchumerD-NY · Jun 5, 2024

Madam President, today, every Senator must take a stand: If you agree all Americans deserve access to contraception, then vote yes on the Right to Contraception Act. This bill simply says that if you…

John Thune
Sen. John ThuneR-SD · Jun 5, 2024

The following Senators are necessarily absent: the Senator from Indiana (Mr. Braun), the Senator from Alabama (Mrs. Britt), the Senator from South Carolina (Mr. Graham), the Senator from Tennessee…

Richard Blumenthal
Sen. Richard BlumenthalD-CT · Jun 4, 2024

Mr. President, I understand there is a bill at the desk, and I ask for its first reading. I ask for a second reading, and in order to place the bill on the calendar under provisions of rule XIV, I…

Joni Ernst
Sen. Joni ErnstR-IA · Jun 5, 2024

Madam President, I understand there is a bill at the desk that is due for a second reading. In order to place the bill on the calendar under the provisions of rule XIV, I would object to further…

Richard J. Durbin
Sen. Richard J. DurbinD-IL · Jun 5, 2024

I announce that the Senator from New Jersey (Mr. Menendez) is necessarily absent.

Bill Text

Latest available legislative text

Reading Mode
Latest
Placed on Calendar SenateIssued June 5, 2024

II

Calendar No. 418

118th CONGRESS

2d Session

S. 4447

IN THE SENATE OF THE UNITED STATES

June 4, 2024

Ms. Ernst (for herself, Mr. Grassley, Mrs. Capito, Mr. Daines, Mr. Young, Mr. Tillis, Mr. Cruz, Mr. McConnell, Mr. Risch, Mr. Cornyn, Mr. Paul, Mr. Thune, and Mr. Marshall) introduced the following bill; which was read the first time

June 5, 2024

Read the second time and placed on the calendar

A BILL

To allow women greater access to safe and effective oral contraceptive drugs intended for routine use, and to direct the Comptroller General of the United States to conduct a study on Federal funding of contraceptive methods.

1.

Short title

This Act may be cited as the Allowing Greater Access to Safe and Effective Contraception Act.

2.

Supplemental applications for over-the-counter contraceptive drugs

(a)

Priority review of application

The Secretary of Health and Human Services (referred to in this section as the Secretary) shall give priority review to any supplemental application submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(b)) if—

(1)

the supplemental application is with respect to an oral contraceptive drug intended for routine use;

(2)

the supplemental application is not with respect to—

(A)

any emergency contraceptive drug; or

(B)

any drug that is also approved for induced abortion; and

(3)

if the supplemental application is approved, with respect to individuals aged 18 and older, such drug would not be subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)(1)).

(b)

Fee waiver

The Secretary shall waive the fee under section 736(a)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379h(a)(1)) with respect to a supplemental application that receives priority review under subsection (a).

(c)

Over-the-Counter availability

Notwithstanding any other provision of law, with respect to individuals under age 18, a contraceptive drug that is eligible for priority review under subsection (a) shall be subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)(1)), including after approval of the supplemental application as described in subsection (a)(3).

(d)

Applicability

This section applies with respect to a supplemental application described in subsection (a) that—

(1)

is submitted before the date of enactment of this Act and remains pending as of such date of enactment; or

(2)

is submitted after such date of enactment.

3.

GAO study and report on Federal funding of contraceptive methods

Not later than one year after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit a report to Congress regarding the amount of Federal funds made available for the purposes of contraception reimbursement, inventory stocking, provider training, or patient education during the 15-year period immediately preceding such date of enactment, including such funding made available through—

(1)

the Medicare program under title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.);

(2)

the Medicaid program under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.);

(3)

the Indian Health Service;

(4)

the American Health Benefit Exchanges established under section 1311 or 1321 of the Patient Protection and Affordable Care Act (42 U.S.C. 18031; 18041);

(5)

Federally-qualified health centers (as defined in section 1905(l)(2)(B) of the Social Security Act (42 U.S.C. 1396d(l)(2)(B)));

(6)

title X of the Public Health Service Act (42 U.S.C. 300 et seq.);

(7)

temporary assistance for needy families under part A of title IV of the Social Security Act (42 U.S.C. 601 et seq.); or

(8)

the TRICARE program (as defined in section 1072 of title 10, United States Code).

June 5, 2024

Read the second time and placed on the calendar